Trials Sponsors Conditions Drugs Pricing

Conditions

Atrial Fibrillation

Outcome Measures

Primary Outcomes (1)

Atrial fibrillation
Symptomatic or asymptomatic AF that is documented by surface ECG. The minimum duration of an ECG tracing of AF required to establish the diagnosis of clinical AF is at least 30 seconds, or entire 12-lead ECG.
through study completion, an average of 2 year

Secondary Outcomes (2)

Atrial high-rate episodes (AHRE)
through study completion, an average of 2 year
Subclinical AF
through study completion, an average of 2 year

Study Arms (1)

Patients with pacemakers without atrial fibrillation at the beginning or in history

Patients with pacemakers without atrial fibrillation at the beginning or in history. Patients are adults over 18 years old.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Patients will be selected from the Arrhythmia Treatment Department of Cho Ray Hospital during the study period. Adult patients with indications for pacemaker placement, agree to participate in the study, meet the inclusion criteria and do not have the exclusion criteria will be selected for the study.

You may qualify if:

Patient is an adult (≥ 18 years old or older)

Sponsors & Collaborators

University of Medicine and Pharmacy at Ho Chi Minh City
Otherlead

Study Sites (1)

Cho Ray Hospital

Ho Chi Minh City, None Selected, 700000, Vietnam

RECRUITING

Thuc T Nguyen, PhD, MDCONTACT+84 02838554137 bvchoray@choray.vn

Linh HK Duong, Master, MDPRINCIPAL INVESTIGATOR

Biospecimen

Retention: SAMPLES WITH DNA

Venous blood samples will be drawn from fasting participants. The blood then will be promptly processed, and serum or plasma will be used for quantification of hs Troponin I or NT-proBNP.

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Linh HK Duong, Master
Cho Ray Hospital
PRINCIPAL INVESTIGATOR

Central Study Contacts

Linh HK Duong, Master, MD

CONTACT

+ 84 0366698048 khanhlinh175@gmail.com

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Duong Ha Khanh Linh

Study Record Dates

First Submitted

November 30, 2023

First Posted

December 18, 2023

Study Start

December 1, 2023

Actual (reported)

Primary Completion

September 30, 2026

Estimated (date passed)

The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Patients with pacemakers without atrial fibrillation at the beginning or in history

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

Study Start

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Patients with pacemakers without atrial fibrillation at the beginning or in history

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations